A Study of MLN0264 in Patients With Pancreatic Cancer

Clinical trial NCT02202785 · TERMINATED

Trial details

NCT number: NCT02202785
Sponsor: Millennium Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2014-07-02
Primary completion: 2016-01-15
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.